BRANFORD, Conn., June 16, 2026 /PRNewswire/ — Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that Cofounder and Chief Operating Officer, Travis Whitfill Ph.D., MPH, will…

Read the full release →

News provided by PR Newswire.